title: Between-cow variation in dermal fibroblast response to lipopolysaccharide reflected in resolution of inflammation during Escherichia coli mastitis.
abstract: Effective response to mammary gland infection depends on efficient early innate immune response. The desired response would be one that is sufficient to clear the infection with a rapid return to the production of high-quality milk and limited tissue damage. In this study, 43 early lactation cows were ranked based on the ability of their fibroblasts to produce IL-8 in response to Escherichia coli lipopolysaccharide. Subsequently, the effect of a low or high response phenotype on the response to E. coli mastitis was determined. Untreated fibroblasts produced no detectable IL-8, whereas the range of IL-8 production in response to LPS (100 ng/mL) was approximately 7-fold between the lowest and highest responding cultures. Similar patterns of between-cow variation were observed in fibroblast production of IL-8 and IL-6 in response to IL-1β and Pam2CSK4 (a synthetic diacylated lipopeptide ligand). Four low and 4 high responder cows were challenged in late lactation with intramammary infusion of E. coli. All cows developed clinical mastitis in the challenged quarters and all cows cleared the infection within 8 d. However, somatic cell count began to decline earlier in the low responder group, and milk BSA concentration (an indicator of tissue damage) was also lower in low responders compared with high responders. Milk production from the challenged quarter was markedly depressed in both groups, but returned toward prechallenge values earlier in low responder cows. Dermal fibroblast cells appear predictive of a cow's response to mastitis. In this study, the low responder phenotype was sufficient to contain an E. coli infection with a more rapid return to the production of high quality milk.
authors: Department of Animal Science, College of Agriculture and Life Sciences, University of Vermont, Burlington, VT 05405, USA.
authors: S
authors: S
authors: Kandasamy
authors: B B
authors: BB
authors: Green
authors: A L
authors: AL
authors: Benjamin
authors: D E
authors: DE
authors: Kerr
mesh_terms: D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000276:immunology* / Q000382:microbiology; D007249:Inflammation / Q000276:immunology / Q000382:microbiology / Q000662:veterinary; D015850:Interleukin-6 / Q000096:biosynthesis; D016209:Interleukin-8 / Q000096:biosynthesis; D055666:Lipopeptides / Q000276:immunology / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000276:immunology* / Q000494:pharmacology; D008414:Mastitis, Bovine / Q000276:immunology* / Q000382:microbiology; D010641:Phenotype; D012867:Skin / Q000166:cytology / Q000276:immunology
chemical_list: D015850:Interleukin-6; D016209:Interleukin-8; D055666:Lipopeptides; D008070:Lipopolysaccharides; C560312:Pam2CSK4 lipopeptide